South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 1.39 trillion. The enterprise value is 2.25 trillion.
| Market Cap | 1.39T |
| Enterprise Value | 2.25T |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 25.62% |
| Float | 5.38M |
Valuation Ratios
The trailing PE ratio is 6.97 and the forward PE ratio is 7.63. KRX:069620's PEG ratio is 1.66.
| PE Ratio | 6.97 |
| Forward PE | 7.63 |
| PS Ratio | 0.88 |
| PB Ratio | 1.21 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.53 |
| PEG Ratio | 1.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.23, with an EV/FCF ratio of -27.39.
| EV / Earnings | 11.28 |
| EV / Sales | 1.42 |
| EV / EBITDA | 8.23 |
| EV / EBIT | 10.30 |
| EV / FCF | -27.39 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.12 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 3.85 |
| Debt / FCF | -10.94 |
| Interest Coverage | 14.57 |
Financial Efficiency
Return on equity (ROE) is 19.07% and return on invested capital (ROIC) is 9.62%.
| Return on Equity (ROE) | 19.07% |
| Return on Assets (ROA) | 5.04% |
| Return on Invested Capital (ROIC) | 9.62% |
| Return on Capital Employed (ROCE) | 9.98% |
| Weighted Average Cost of Capital (WACC) | 3.07% |
| Revenue Per Employee | 968.49M |
| Profits Per Employee | 121.57M |
| Employee Count | 1,644 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, KRX:069620 has paid 2.43 billion in taxes.
| Income Tax | 2.43B |
| Effective Tax Rate | 1.21% |
Stock Price Statistics
The stock price has decreased by -25.71% in the last 52 weeks. The beta is -0.01, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -25.71% |
| 50-Day Moving Average | 146,154.00 |
| 200-Day Moving Average | 154,848.00 |
| Relative Strength Index (RSI) | 31.07 |
| Average Volume (20 Days) | 38,374 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.59 trillion and earned 199.86 billion in profits. Earnings per share was 17,369.40.
| Revenue | 1.59T |
| Gross Profit | 820.61B |
| Operating Income | 179.02B |
| Pretax Income | 201.07B |
| Net Income | 199.86B |
| EBITDA | 234.02B |
| EBIT | 179.02B |
| Earnings Per Share (EPS) | 17,369.40 |
Balance Sheet
The company has 168.03 billion in cash and 900.43 billion in debt, with a net cash position of -732.39 billion or -63,651.80 per share.
| Cash & Cash Equivalents | 168.03B |
| Total Debt | 900.43B |
| Net Cash | -732.39B |
| Net Cash Per Share | -63,651.80 |
| Equity (Book Value) | 1.15T |
| Book Value Per Share | 89,167.40 |
| Working Capital | 81.13B |
Cash Flow
In the last 12 months, operating cash flow was 163.33 billion and capital expenditures -245.62 billion, giving a free cash flow of -82.29 billion.
| Operating Cash Flow | 163.33B |
| Capital Expenditures | -245.62B |
| Depreciation & Amortization | 55.00B |
| Net Borrowing | 226.69B |
| Free Cash Flow | -82.29B |
| FCF Per Share | -7,151.36 |
Margins
Gross margin is 51.54%, with operating and profit margins of 11.24% and 12.55%.
| Gross Margin | 51.54% |
| Operating Margin | 11.24% |
| Pretax Margin | 12.63% |
| Profit Margin | 12.55% |
| EBITDA Margin | 14.70% |
| EBIT Margin | 11.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.53% |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.52% |
| Earnings Yield | 14.34% |
| FCF Yield | -5.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KRX:069620 is 207,272.73, which is 75.66% higher than the current price. The consensus rating is "Buy".
| Price Target | 207,272.73 |
| Price Target Difference | 75.66% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 2.84% |
| EPS Growth Forecast (3Y) | 5.23% |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 4 |